Gene · 8900
Papers2,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HREM, RNAseq and Cell Cycle Analyses Reveal the Role of the G2/M-Regulatory Protein, WEE1, on the Survivability of Chicken Embryos during Diapause. | Biomedicines | 2022 | 35453529 | PubTator, text mining | PubMed |
| The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma. | Transl Oncol | 2022 | 35452995 | PubTator, text mining | PubMed |
| Anticancer activity of chicken cathelicidin peptides against different types of cancer. | Mol Biol Rep | 2022 | 35449320 | PubTator, text mining | PubMed |
| Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation. | BMC Gastroenterol | 2022 | 35448958 | PubTator, text mining | PubMed |
| BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors. | Front Oncol | 2022 | 35444937 | PubTator, text mining | PubMed |
| Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model. | Explor Target Antitumor Ther | 2022 | 35441158 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription. | Nat Commun | 2022 | 35440621 | PubTator, text mining | PubMed |
| SMN-deficient cells exhibit increased ribosomal DNA damage. | Life Sci Alliance | 2022 | 35440492 | PubTator, text mining | PubMed |
| MiR-372-3p Functions as a Tumor Suppressor in Colon Cancer by Targeting MAP3K2. | Front Genet | 2022 | 35432472 | PubTator, text mining | PubMed |
| SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma. | Cancers (Basel) | 2022 | 35406445 | PubTator, text mining | PubMed |
| Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer. | Front Oncol | 2022 | 35402283 | PubTator, text mining | PubMed |
| A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles. | Front Pharmacol | 2022 | 35401196 | PubTator, text mining | PubMed |
| MOXD1 knockdown suppresses the proliferation and tumor growth of glioblastoma cells via ER stress-inducing apoptosis. | Cell Death Discov | 2022 | 35393406 | PubTator, text mining | PubMed |
| Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic? | Front Oncol | 2022 | 35387114 | PubTator, text mining | PubMed |
| PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer. | Front Cell Dev Biol | 2022 | 35386201 | PubTator, text mining | PubMed |
| Impact of chronic exposure of rats to bisphenol A from perinatal period to adulthood on intraprostatic levels of 5α-reductase isozymes, aromatase, and genes implicated in prostate cancer development. | Environ Res | 2022 | 35378123 | PubTator, text mining | PubMed |
| Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges. | Front Oncol | 2022 | 35356211 | PubTator, text mining | PubMed |
| Rac GTPases in acute myeloid leukemia cells: Expression profile and biological effects of pharmacological inhibition. | Toxicol Appl Pharmacol | 2022 | 35331739 | PubTator, text mining | PubMed |
| Increasing Role of Targeted Immunotherapies in the Treatment of AML. | Int J Mol Sci | 2022 | 35328721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8900/papers?page=19